Sharps Technology receives $100k initial purchase order from Hungarian provider

Sharps Technology (STSS) announces the receipt of a $100,000 purchase order from a Hungarian vaccine provider. This order supports the recently announced $400,000 SoloGard order, which is part of a broader $50 million agreement that was previously announced with a U.S. company and represents the first SecureGard order from this Hungary-based company. “I am pleased to announce our second significant purchase order to date, bringing our total orders received for Q2 to approximately $500,000,” stated Robert Hayes, Chief Executive Officer of Sharps Technology. “These latest orders mark the first for our SecureGard and Disgard product lines, and we are excited to begin what we anticipate will be a long-term relationship with these customers. With this milestone, Sharps has officially transitioned into a commercial-stage company, which is a pivotal moment in our growth trajectory.”